Table 3.
The effect of the type of drug resistance or history of TB treatment on the proportion of treatment success of the two groups
| Indicators | BDQ group (n = 102) | Non-BDQ group (n = 100) | p value | ||
|---|---|---|---|---|---|
| Success | Others | Success | Others | ||
| Type of drug resistance (n, %) | |||||
| RR | 3 (100.0) | 0 (0.0) | 2 (40.0) | 3 (60.0) | 0.20 |
| MDR | 69 (93.2) | 5 (6.8) | 47 (69.1) | 21 (30.9) | < 0.001* |
| XDR | 22 (88.0) | 3 (12.0) | 14 (51.9) | 13 (48.1) | 0.005* |
| History of TB treatment (n, %) | |||||
| New cases | 10 (90.9) | 1 (9.1) | 6 (75.0) | 2 (25.0) | 0.55 |
| One-time history of TB treatment | 34 (91.9) | 3 (8.1) | 18 (72.0) | 7 (28.0) | 0.04* |
| Two-time history of TB treatment | 29 (90.6) | 3 (9.4) | 27 (71.1) | 11 (28.9) | 0.04* |
| ≥ Three-time history of TB treatment | 21 (95.5) | 1 (4.5) | 12 (41.4) | 17 (58.6) | < 0.001* |
| MDR/RR-TB | (n = 77) | (n = 73) | |||
| New cases | 7 (100.0) | 0 (0.0) | 5 (71.4) | 2 (28.6) | 0.46 |
| One-time history of TB treatment | 30 (90.9) | 3 (9.1) | 16 (76.2) | 5 (23.8) | 0.14 |
| Two-time history of TB treatment | 21 (95.5) | 1 (4.5) | 20 (76.9) | 6 (23.1) | 0.07 |
| ≥ Three-time history of TB treatment | 14 (93.3) | 1 (6.7) | 8 (42.1) | 11 (57.9) | 0.003* |
| XDR-TB | (n = 25) | (n = 27) | |||
| New cases | 3 (75.0) | 1 (25.0) | 1 (100.0) | 0 (0.0) | 1.00 |
| One-time history of TB treatment | 4 (100.0) | 0 (0.0) | 2 (50.0) | 2 (50.0) | 0.432 |
| Two-time history of TB treatment | 8 (80.0) | 2 (20.0) | 7 (77.8) | 5 (22.2) | 1.00 |
| ≥ Three-time history of TB treatment | 7 (100.0) | 0 (0.0) | 4 (40.0) | 6 (60.0) | 0.04* |
TB tuberculosis, n number, RR rifampicin-resistant, MDR multidrug-resistant, XDR extensively drug-resistant, BDQ bedaquiline
* the differences had statistical significance (p < 0.05)